Skip to content
Back to event

KalshiKalshi· Politics

Will legislation that limits out-of-pocket costs for insulin for privately insured patients to no more than $40 per month, per 30-day supply, or equivalent monthly period become law before Jan 1, 2027?

Chance

20%

Buy Yes

22¢

pays $1 if it happens

Buy No

82¢

pays $1 if it doesn’t

Prices from Kalshi, updated 11 minutes ago. Ends Jan 1, 3:00 PM UTC.

Price over the last 2 weeks
Cost of a Yes share

Latest trades

  • 4 hours agoSold yes at 22¢$22
  • 4 hours agoSold yes at 21¢$2
How this market is decidedShow

If legislation that limits out-of-pocket costs for insulin for privately insured patients to no more than $40 per month, per 30-day supply, or equivalent monthly period has become law after Issuance and before Jan 1, 2027, then the market resolves to Yes. Clarification: 'FISA Section 702 reauthorization (2 years)' (KXBILLS-FISA) resolves to Yes only if FISA Section 702 is reauthorized for exactly two years, as in the provided example (Public Law 118-49). A reauthorization for any other duration would not qualify. Clarification: To be clear, legislation that appropriates funds for security adjustments and upgrades relating to the East Wing Modernization Project, a project that includes the construction of a presidential ballroom, constitutes legislation that "authorizes funding for construction of a presidential ballroom," even if the funds are restricted to security elements of that construction.